Literature DB >> 24447650

Age-distribution and genotype-phenotype correlation for N-acetyltransferase in Argentine children under isoniazid treatment.

Guillermo Alberto Keller, Lucas Fabian, Matías Gomez, Claudio Daniel Gonzalez, Roberto Alejandro Diez, Guillermo Di Girolamo.   

Abstract

INTRODUCTION: Metabolic clearance of isoniazid (INH) may be up to 10 times faster in individuals who are rapid acetylators compared with slow acetylators. In addition, the acetylation phenotype has been suggested to change with age. A better knowledge of the age distribution of the acetylation genotype and phenotype in children requiring INH for tuberculosis treatment or prevention could be important to optimize safety and efficacy of INH use.
OBJECTIVES: The aim of the present study was to evaluate the genotype and phenotype of NAT2 in an Argentinean pediatric population rom Buenos Aires. In addition, we wanted to describe genotype-phenotype correlation, as well as its distribution at different ages.
METHODOLOGY: NAT2 genotyping was performed by RFLP technique, searching for common polymorphisms. Acetylisoniazid and isoniazid concentrations were measured by HPLC and NAT2 phenotype was defined from the ratio of both concentrations (Metabolic Ratio, MR).
RESULTS: Almost half of the patients (46.02%) possessed wild-type haplotype, with 17.05% of individuals having two fully functional alleles, 57.95% one fully functional allele and 25% with no fully functional allele. According to phenotype, most children (96.59%) were classified as fast acetylators, whereas 1.14% of the cases were intermediate and 2.27% slow acetylators. There was a positive association between age and MR (R = 0.52985, p < 0.000001) with a significant MR difference between age categories (p < 0.001).
CONCLUSIONS: We found a high proportion of rapid acetylators compared with other populations. Acetylator phenotype showed a positive correlation with age, with a significant change around the 4th year of life.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24447650     DOI: 10.5414/CP201957

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  2 in total

1.  Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure.

Authors:  Agathe Béranger; Adrie Bekker; Belén P Solans; Mark F Cotton; Mark Mirochnick; Avy Violari; Jiajia Wang; Mae Cababasay; Lubbe Wiesner; Renee Browning; Jack Moye; Edmund V Capparelli; Radojka M Savic
Journal:  Clin Infect Dis       Date:  2022-09-29       Impact factor: 20.999

Review 2.  The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review.

Authors:  Nadir Yalçin; Robert B Flint; Ron H N van Schaik; Sinno H P Simons; Karel Allegaert
Journal:  Pharmgenomics Pers Med       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.